ASX CODE: PAA

PharmAust ASX PAA Monepantel tablets Phase 1 dogs

PharmAust reports positive results from phase I anti-cancer tablet trial on dogs

Clinical-stage oncology company PharmAust (ASX: PAA) has received early positive results from a phase I trial of its reformulated monepantel anti-cancer tablets. The canine-based trial...
Read more
PharmAust ASX PAA monepantel clinical trials humans canine dog anti-cancer tablet

PharmAust to begin anti-cancer tablet trials in dogs this month

Oncology company PharmAust (ASX: PAA) has manufactured its first batch of monepantel anti-cancer tablets in readiness for the phase I clinical trial in dogs,...
Read more
PharmAust ASX PAA principal metabolite anti cancer properties monepantel

PharmAust’s principal metabolite confirmed to have anti-cancer properties

Oncology company PharmAust (ASX: PAA) has revealed positive news in relation to its ongoing development of monepantel, with the company confirming that monepantel’s major metabolite...
Read more
PharmAust ASX PAA upscale cancer drug candidate Monepantel Syngene International

PharmAust readies to upscale its flagship cancer drug candidate Monepantel

Clinical-stage oncology company PharmAust (ASX: PAA) could be set to upscale development of its flagship drug candidate ‘Monepantel’, a cancer drug that is potentially...
Read more
PharmAust ASX PAA treat cancer dogs oncology

PharmAust targets unique market for treating cancer in dogs

Australian vets and dog-lovers could soon have an additional weapon in their toolkit to treat cancer in dogs, courtesy of a novel therapy to...
Read more
PharmAust ASX PAA secures US patent cancer drugs

PharmAust secures US patent for cancer drugs

PharmAust (ASX: PAA) has locked in a US patent for its aminoacetonitrile compound drug portfolio, which have anti-cancer properties. “Allowance of this patent secures PharmAust’s...
Read more

RECENT POSTS

STOCK SUMMARY

INVESTOR TOOLS

HOT TOPICS

TRENDING POSTS

Small Caps ASX Australian stock market
Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.

Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.
Copyright 2019 Small Caps. All rights reserved.